NOW Royal Jelly 1500mg Caps May Contain Metronidazole
NOW Health recalls 60-count Royal Jelly 1500mg capsules due to potential metronidazole contamination. Consumers should check UPC 733739025654 for affected lots.
Lower-risk recall
Product may contain Metronidazole
Contact the company
What happened, in plain English
NOW Health is recalling 60-count Royal Jelly 1500mg capsules because they may contain metronidazole. This could pose a health risk if consumed, especially for people taking metronidazole medications. Read more at govinfonow.com/recall/14085-now-royal-jelly-1500mg-caps-may-contain-metronidazole.
Source Summary by GovInfoNow · govinfonow.com/recall/14085-now-royal-jelly-1500mg-caps-may-contain-metronidazole · Updated October 4, 2026 · FDA enforcement record: FDA #F-0155-2022
Cite this page
“NOW Royal Jelly 1500mg Caps May Contain Metronidazole.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/14085-now-royal-jelly-1500mg-caps-may-contain-metronidazole. Based on FDA recall #F-0155-2022 (https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-0155-2022%22&limit=1).
Why it’s dangerous
Metronidazole is an antibiotic that can cause side effects like nausea, dizziness, and allergic reactions. If the product contains metronidazole, it may interact with medications or cause health issues for some users.
Who’s affected
People who own or use NOW Royal Jelly 1500mg capsules with UPC 733739025654 are affected. Those taking metronidazole medications or sensitive to its side effects are at higher risk.
How to tell if you have this one
Check for the UPC 733739025654 on the product packaging. The product is distributed by Sofico and includes specific lot numbers.
- Brand
NOW Health- Product
NOW Royal Jelly 1500mg 60 VCAPS UPC 733739025654 NOW Royal Jelly 1500mg 60 VCAPS (Distributed by Sofico) UPC- Category
Food
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Terminated- Distribution
Total number of domestic consignees = 1576 (including 2 private label customers). Domestic online and retail to AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WY. Total number of foreign consignees = 21 (including 1 private label customer). International distribution to retail locations in Bulgaria, Cameroon, Canada, England, Germany, Holland, Kazakhstan, Netherlands, Nigeria, Poland, Singapore, Slovakia, Sweden, Ukraine, and United Arab Emirates. International distribution to a distributor in Cairo, Egypt.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| F-0155-2022 | NOW Royal Jelly 1500mg 60 VCAPS UPC 733739025654 NOW Royal Jelly 1500mg 60 VCAPS (Distributed by Sofico) UPC 733739150523 Lifesource Vitamins 1500mg 60 Veg Caps UPC 610265580430; Lots: 3203587 3172171 3184045 3214752 (Lifesource) 3184027 (Sofico) | 88,890 units |
| F-0156-2022 | NOW Ginseng & Royal Jelly 90 VCAPS UPC 733739040077 MMA Nutrition Ginselin 90 Veg Capsules UPC 733739440075; Lots: 3168920 3217381 3219743 (MMA Nutrition) | 7,935 units |
| F-0157-2022 | NOW Bee Pollen 500mg 100 VCAPS UPC 733739025203; Lots: 3209226 3184250 | 33,056 units |
What to do — step by step
Check Product UPC
Look for the UPC 733739025654 on the capsule packaging to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed in 47 states, and outside the U.S.
FDA distribution: “Total number of domestic consignees = 1576 (including 2 private label customers). Domestic online and retail to AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, Wyoming.
Recall timeline
FDA terminated this recall 2.9 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest food recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #F-0155-2022 (October 1, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for F-0155-2022 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.